SCHEMBL14282934

SCHEMBL14282934

O=C(CN1CCC(=C(c2ccccc2)c2ccccc2)CC1)OC1CCOCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
OPRD1 P41143 7/20 0.44
OPRK1 P41145 6/20 0.44
OPRM1 P35372 5/20 0.44
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
SETD7 Q8WTS6 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
HTR7 P34969 1/20 0.40
ALDH1A1 P00352 3/20 0.40
P2RX7 Q99572 1/20 0.39
FNTA P49354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14282933 0.93 DRD2 (0.43) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14282936 0.88 ALDH1A1 (0.48) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14282935 0.82 ALDH1A1 (0.43) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL4697602 0.77 ALDH1A1 (0.46) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14282960 0.75 BCHE (0.50) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14282904 0.75 OPRD1 (0.50) OPRD1OPRK1OPRM1MEN1POLB
SCHEMBL4257154 0.74 SETD7 (0.56) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL11036336 0.72 SETD7 (0.53) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL5185766 0.70 KMT2A (0.59) MEN1POLBKMT2ALMNAMAPT
SCHEMBL24177749 0.70 KDM4E (0.42) MEN1POLBKMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7317026-B2 Sleep disorders; side effect reduction ; antihistamine antagonist HYPNION, INC. (US) 2008-01-08 US disclosed
US-7317026-B2 Sleep disorders; side effect reduction ; antihistamine antagonist HYPNION, INC. (US) 2008-01-08 US disclosed
US-7189757-B2 Treatment of sleep disorders using CNS target modulators HYPNION, INC. (US) 2007-03-13 US disclosed
US-7189757-B2 Treatment of sleep disorders using CNS target modulators HYPNION, INC. (US) 2007-03-13 US disclosed